Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Harmony Biosciences Holdings, Inc.(HRMY) | 368,665 | 368,665 | 0 | $12.69M | $12.24M | 9.98% | -$449.8K |
| Oculis Holding AG(OCS) | 436,378 | 514,702 | +78,324 | $7.42M | $9.79M | 7.99% | +$2.38M |
| Illumina, Inc.(ILMN) | 119,196 | 119,196 | 0 | $15.93M | $9.46M | 7.71% | -$6.47M |
| Verona Pharma PlcADS | 133,040 | 147,990 | +14,950 | $6.18M | $9.40M | 7.66% | +$3.22M |
| Zai Lab LimitedADR(ZLAB) | 235,000 | 253,675 | +18,675 | $6.15M | $9.17M | 7.48% | +$3.01M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 125,330 | 146,765 | +21,435 | $5.18M | $6.61M | 5.39% | +$1.43M |
| Protagonist Therapeutics Inc | 0 | 121,400 | +121,400 | $0 | $5.87M | 4.79% | +$5.87M |
| Soleno Therapeutics Inc | 79,650 | 79,650 | 0 | $3.58M | $5.69M | 4.64% | +$2.11M |
| Xenon Pharmaceuticals Inc.(XENE) | 106,680 | 158,605 | +51,925 | $4.18M | $5.32M | 4.34% | +$1.14M |
| Merus N V | 120,038 | 120,038 | 0 | $5.05M | $5.05M | 4.12% | +$4.8K |
| BeOne Medicines AGADR(ONC) | 19,997 | 15,722 | -4,275 | $3.69M | $4.28M | 3.49% | +$585.4K |
| Replimune Group, Inc.(REPL) | 321,746 | 414,246 | +92,500 | $3.90M | $4.04M | 3.29% | +$142.6K |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 11,122 | 11,872 | +750 | $3.43M | $3.93M | 3.21% | +$500.4K |
| Incyte Corporation(INCY) | 67,022 | 59,022 | -8,000 | $4.63M | $3.57M | 2.91% | -$1.06M |
| Recursion Pharmaceuticals, Inc.CL A(RXRX) | 664,610 | 664,610 | 0 | $4.49M | $3.52M | 2.87% | -$977.0K |
| Tourmaline Bio Inc | 187,090 | 227,090 | +40,000 | $3.79M | $3.45M | 2.82% | -$340.1K |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 49,120 | 49,120 | 0 | $2.75M | $2.60M | 2.12% | -$147.9K |
| Exelixis, Inc.(EXEL) | 64,200 | 64,200 | 0 | $2.14M | $2.37M | 1.93% | +$232.4K |
| Geron Corporation(GERN) | 1,373,550 | 1,373,550 | 0 | $4.86M | $2.18M | 1.78% | -$2.68M |
| Ascendis Pharma A/SADR(ASND) | 13,600 | 13,600 | 0 | $1.87M | $2.12M | 1.73% | +$247.4K |
| Standard BioTools Inc.(LAB) | 1,883,179 | 1,883,179 | 0 | $3.30M | $2.03M | 1.66% | -$1.26M |
| Kalvista Pharmaceuticals Inc | 154,522 | 154,522 | 0 | $1.31M | $1.78M | 1.45% | +$474.4K |
| Acadia Pharmaceuticals Inc | 102,984 | 102,984 | 0 | $1.89M | $1.71M | 1.40% | -$179.2K |
| argenx SEADR(ARGX) | 430 | 2,800 | +2,370 | $264.4K | $1.66M | 1.35% | +$1.39M |
| Kymera Therapeutics, Inc.(KYMR) | 30,875 | 30,875 | 0 | $1.24M | $845.0K | 0.69% | -$397.1K |
| Revolution Medicines, Inc.(RVMD) | 19,253 | 19,253 | 0 | $842.1K | $680.8K | 0.56% | -$161.3K |
| Rani Therapeutics Holdings, Inc.CL A(RANI) | 493,584 | 493,584 | 0 | $676.2K | $621.9K | 0.51% | -$54.3K |
| Bicycle Therapeutics PlcADS | 68,943 | 68,943 | 0 | $965.2K | $585.3K | 0.48% | -$379.9K |
| Climb Bio, Inc.(CLYM) | 463,654 | 463,654 | 0 | $834.6K | $565.7K | 0.46% | -$268.9K |
| Bolt Biotherapeutics Inc | 1,166,952 | 1,166,952 | 0 | $624.4K | $466.8K | 0.38% | -$157.7K |
| Entrada Therapeutics, Inc.(TRDA) | 49,082 | 49,082 | 0 | $848.6K | $443.7K | 0.36% | -$404.9K |
| DBV Technologies S.A.ADS(DBVT) | 37,095 | 37,095 | 0 | $114.6K | $253.0K | 0.21% | +$138.4K |
| Bolt Projs Hldgs Inc | 811,952 | 811,952 | 0 | $391.4K | $249.5K | 0.20% | -$141.8K |
| Affimed N V | 37,247 | 37,247 | 0 | $44.3K | $26.9K | 0.02% | -$17.4K |
| ALX Oncology Holdings Inc.(ALXO) | 41,950 | 41,950 | 0 | $70.1K | $26.1K | 0.02% | -$43.9K |
| Rubrik, Inc.CL A(RBRK) | 24,338 | 0 | -24,338 | $1.59M | $0 | — | -$1.59M |